Clinical & Translational Immunology
The Official Open Access Journal of the ASI
2022 Impact Factor: 5.8
2022 Scopus CiteScore: 9.6
CLINICAL & TRANSLATIONAL IMMUNOLOGY COVERS:
- Cancer biology
- Cardiovascular research
- Gene therapy
- Immunology
- Vaccine development
- Disease pathogenesis and therapy at the earliest phases of investigation
FEATURES OF CLINICAL & TRANSLATIONAL IMMUNOLOGY INCLUDE:
- Rapid Review Process
- Average Time to First Decision of 13 days (2022 manuscripts)
- Open Access – anyone can download and read your paper
- 2022 Impact Factor 5.8
- 2022 Scopus CiteScore 9.6
- Now listed on PubMed Central
- Full peer review
- Original Articles, Reviews, Case Reports, Letters to Editors, Theoretical Articles, Short Communications
- Special Features
- Supported by a distinguished and international Editorial Board
- Member of COPE for responsible publication ethics
- Publishes only the most important advances in biomedical research
- Eligibility for the CTI Social Impact Award
ADDITIONAL BENEFITS FOR ASI MEMBERS
- Receive a 20% discount off the cost of publishing in CTI*
- Be in the running for the award of ‘CTI Publication of the Year’, which also includes a speakers slot at the ASI annual meeting***
*Eligible only to current financial ASI members. To receive the member-only code, please contact us. For further information about the Wiley-CAUL agreement, which covers the APC (Article Processing Charge) for authors, see https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/affiliation-policies-payments/institutional-funder-payments.html
***Awarded to the best publication from a current financial ASI member who is first author.
CTI website Submit a manuscript Download the CTI flyer
